Phenotypic Divergence of <i>JAG1</i> ‐ and <i>NOTCH2</i> ‐Associated Alagille Syndrome & Disease‐Specific <i>NOTCH2</i> Variant Classification GuidelinesShannon M. Vandriel, Chatmanee Lertudomphonwanit, Jian‐She Wang et al.|Liver International|2025Cited by 4
OC7 Maralixibat-treated patients with Alagille syndrome demonstrate event-free survival in a natural history comparison with patients with from the GALA database: application of real-world evidence analyticsBE Hansen, SM Vandriel, Pamela Vig et al.|Abstracts|2023Cited by 0